To view this email as a web page, click here.

TOP STORIES
 
Five ways to improve patient medication adherence
Here are five ways healthcare organizations of all types, including managed care organizations, can improve patient adherence to prescribed medication therapies.
Read more
 
Is there a simple fix for the Part D discount program?
A poll from the Biosimilars Council, a division of the Association for Accessible Medicines, has interesting findings about placing biosimilars and branded biologics on a level playing field to save money.
Read more
 
ICER-VA alliance for formulary management sparks debate
The National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.
Read more
 
ADVERTISEMENT
Navigating the coder shortage
A breakdown of the current state of the medical coder shortage, and visual roadmap to help ambulatory facilities overcome avoidable backlog, denials and compliance risks. Learn More
 
DIGITAL EDITION
Check out our latest issue featuring:
 • Cancer treatment: Top 4 developments to watch
 • Ten ways multiple myeloma treatment is changing
 • Four ways genetic testing is changing cancer care
Read more
 
ADVERTISEMENT
Health Care Executive Toolkit
The resources within this toolkit are designed to help you take immediate action to assess, refine and expand your organization’s ability to deliver improved care quality while controlling costs. Learn More
 
ADVERTISEMENT
[EXCLUSIVE] Healthcare Executive Guide
Intended for ambulatory and outpatient facilities, this guide will address a key concern for many healthcare executives: Should physicians be assigning their own codes? Download this guide now to find the best practices of who should be doing the coding at your facility and the risks and cost of coding mistakes.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.